Literature DB >> 31950466

Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region.

Jen-Chieh Lee1, Hsuan-Ying Huang2.   

Abstract

Giant cell-rich lesions represent a heterogeneous group of tumors and non-neoplastic lesions, usually arising in bone, which harbor varying number of reactive osteoclastic-type multinucleate giant cells as a common feature. Among these entities, some are confined to the head and neck region (e.g., central giant cell granuloma and mimicking lesions, i.e., peripheral giant cell granuloma and cherubism) or show a relative predilection for this region (e.g., aneurysmal bone cyst and brown tumor of hyperparathyroidism), while others are rare but associated with distinct underlying disease (e.g., giant cell tumor of bone) or histology (e.g., tenosynovial giant cell tumor of the temporomandibular joint and phosphaturic mesenchymal tumor of the jaws) when occurring in the head and neck. Collectively, these lesions pose great challenge in the pathologic diagnosis, which often requires combinatory assessment from the clinical, histopathologic, and/or molecular aspects. This review provides a summary of pertinent clinical and pathologic features and an update of recent molecular and genetic findings of these entities. The considerations in differential diagnosis as well as the effects of the emerging therapeutic RANKL-antagonizing antibody denosumab will also be addressed.

Entities:  

Keywords:  Aneurysmal bone cyst; Brown tumor of hyperparathyroidism; Central giant cell granuloma; Giant cell tumor of bone; Phosphaturic mesenchymal tumor; Tenosynovial giant cell tumor

Mesh:

Year:  2020        PMID: 31950466      PMCID: PMC7021864          DOI: 10.1007/s12105-019-01086-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  94 in total

1.  Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.

Authors:  Shogo Tajima; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Emphasis on the MR imaging findings of brown tumor: a report of five cases.

Authors:  Won Sun Hong; Mi Sook Sung; Kyung-Ah Chun; Jee-Young Kim; Sun-Won Park; Kee-Haeng Lee; Hyun Wook Lim; Yeon Soo Lim; Won Jong Yoo; Myung Hee Chung
Journal:  Skeletal Radiol       Date:  2010-06-13       Impact factor: 2.199

3.  Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis.

Authors:  Ksenya V Shelekhova; Dmitry V Kazakov; Ondrej Hes; Vladislav Treska; Michal Michal
Journal:  Virchows Arch       Date:  2006-01-31       Impact factor: 4.064

4.  Primary malignant giant cell tumor of bone: "dedifferentiated" giant cell tumor.

Authors:  J M Meis; H D Dorfman; S D Nathanson; A M Haggar; K K Wu
Journal:  Mod Pathol       Date:  1989-09       Impact factor: 7.842

5.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

6.  Pediatric giant cell tumor of the tendon sheath of the craniocervical junction involving the occipital condyle.

Authors:  Jin Mo Cho; Jong Hee Chang; Sun Ho Kim; Kyu Sung Lee
Journal:  Childs Nerv Syst       Date:  2015-07-26       Impact factor: 1.475

7.  Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.

Authors:  Hidetaka Yamamoto; Takeshi Iwasaki; Yuichi Yamada; Yoshihiro Matsumoto; Hiroshi Otsuka; Masato Yoshimoto; Kenichi Kohashi; Kenichi Taguchi; Ryohei Yokoyama; Yasuharu Nakashima; Yoshinao Oda
Journal:  Hum Pathol       Date:  2017-12-12       Impact factor: 3.466

8.  Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy.

Authors:  Stephen F Hodgson; Bart L Clarke; Peter J Tebben; Brian P Mullan; William P Cooney; Thomas C Shives
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

9.  Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.

Authors:  Naoki Uramoto; Mitsuru Furukawa; Tomokazu Yoshizaki
Journal:  Auris Nasus Larynx       Date:  2008-03-07       Impact factor: 1.863

10.  Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab.

Authors:  Willem H Schreuder; Annet W Coumou; Peter A H W Kessler; Jan de Lange
Journal:  J Oral Maxillofac Surg       Date:  2014-02-18       Impact factor: 1.895

View more
  5 in total

1.  Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study.

Authors:  Yoon Ji Jina Rhou; Che-Jen Wang; Minh Nguyen; Joel A Vanderniet; Craig F Munns; Hedley Coleman; James Kim; Deborah Jane Holmes-Walker; Lydia Lim; Christian M Girgis
Journal:  Calcif Tissue Int       Date:  2022-01-28       Impact factor: 4.333

2.  Giant cell tumor in the thyroid area: a case report in the novel location and review of literature.

Authors:  Jia-Ying Chen; Qiang Zheng; Tong-Zhen Chen; Qing-Hai Ji; Qiang Shen
Journal:  Gland Surg       Date:  2021-06

3.  The clinical challenges and dilemma in the management of uncommon maxillary sinus tumors - A report of two cases.

Authors:  Siddhanth Jain; Shivakumar Thiagarajan; Poonam Panjwani; Pranav Sathe; Mukta Ramadwar
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

4.  Spinal giant cell-rich osteosarcoma-diagnostic dilemma and treatment strategy: A case report.

Authors:  Chen-Sheng Tseng; Chia-En Wong; Chi-Chen Huang; Hao-Hsiang Hsu; Jung-Shun Lee; Po-Hsuan Lee
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

5.  Computed tomography and magnetic resonance imaging characteristics of giant cell tumors in the temporomandibular joint complex.

Authors:  Yoon Joo Choi; Chena Lee; Kug Jin Jeon; Sang-Sun Han
Journal:  Imaging Sci Dent       Date:  2021-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.